Growth Metrics

Legend Biotech (LEGN) FCF Margin (2019 - 2025)

Legend Biotech (LEGN) posted FCF Margin of 3.98% for Q4 2025, down 132.09% on a QoQ basis from 12.41% in Q3 2025, and up 5389.0% year-over-year from 0.07% in Q4 2024.

Legend Biotech (LEGN) has 7 years of FCF Margin data on file, last reported at 3.98% in Q4 2025.

  • In Q4 2025, FCF Margin rose 5389.0% year-over-year to 3.98%; the TTM figure through Dec 2025 stood at 8.16% (up 1705.0% YoY), while the FY2025 annual figure was 9.74%, up 1547.0% from the prior year.
  • FCF Margin declined to 3.98% in Q4 2025, from 12.41% in the prior quarter.
  • Across five years, FCF Margin topped out at 23.15% in Q1 2024 and bottomed at 400.74% in Q4 2021.
  • A 5-year average of 103.87% and a median of 57.82% in 2023 frame the typical range for FCF Margin.
  • Annual changes were most pronounced in 2023 — FCF Margin slumped 23834 bps — and 2024, when it soared 39452 bps.
  • Year by year, FCF Margin stood at 400.74% in 2021, then jumped by 74 bps to 104.28% in 2022, then jumped by 100 bps to 0.17% in 2023, then plunged by 34880 bps to 57.87% in 2024, then jumped by 93 bps to 3.98% in 2025.
  • The last three FCF Margin figures came in at 3.98% (Q4 2025), 12.41% (Q3 2025), and 1.5% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 43.35%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.17%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -3.98%
Sep 30, 2025 12.41%
Jun 30, 2025 -1.50%
Mar 31, 2025 -52.17%
Dec 31, 2024 -57.87%
Sep 30, 2024 -46.04%
Jun 30, 2024 0.95%
Mar 31, 2024 23.15%
Dec 31, 2023 -0.17%
Sep 30, 2023 -57.77%
Jun 30, 2023 -124.75%
Mar 31, 2023 -371.37%
Dec 31, 2022 -104.28%
Sep 30, 2022 -254.14%
Jun 30, 2022 -8.87%
Mar 31, 2022 -133.03%
Dec 31, 2021 -400.74%
Sep 30, 2021 -196.14%
Jun 30, 2021 -217.91%
Mar 31, 2021 -83.17%
Dec 31, 2020 -482.43%
Sep 30, 2020 -487.61%
Jun 30, 2020 -490.39%
Mar 31, 2020 -396.64%
Dec 31, 2019 -308.42%
Sep 30, 2019 112.86%
Jun 30, 2019 -384.32%